Literature DB >> 24052088

Beam controlled arc therapy--a delivery concept for stationary targets.

H H Zhang1, G T Betzel, B Y Yi, W D D'Souza.   

Abstract

Volumetric modulated arc therapy (VMAT) presupposes that it is beneficial to deliver radiation from all beam angles as the gantry rotates, requiring the multi-leaf collimator to maintain continuity in shape from one angle to another. In turn, radiation from undesirable beam angles could compromise the dose distribution. In this work, we challenge the notion that the radiation beam must be held on as the gantry rotates around the patient. We propose a new approach for delivering intensity-modulated arc therapy, beam-controlled arc therapy (BCAT), during which the radiation beam is controlled on or off and the dose rate is modulated while the gantry rotates around the patient. We employ linear-programming-based dose optimization to each aperture weight, resulting in some zero weight apertures. During delivery, the radiation beam is held off at control points with zero weights as the MLC shape transits to the next non-zero weight shape. This was tested on ten head and neck cases. Plan quality and delivery efficiency were compared with VMAT. Improvements of up to 17% (p-value 0.001) and 57% (p-value 0.018) in organ-at-risk sparing and target dose uniformity, respectively, were achieved. Compared to the fixed number of apertures used in single-arc and double-arc VMAT, the BCAT used 109 and 175 apertures on average, respectively. The difference in total MUs for VMAT and BCAT plans was less than 4%. Plan quality improvement was confirmed after delivery with γ analysis resulting in over 99% agreement, or 4 in 1099 points that failed.

Entities:  

Mesh:

Year:  2013        PMID: 24052088     DOI: 10.1088/0031-9155/58/20/7117

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  1 in total

1.  Improving Delivery Accuracy of Stereotactic Body Radiotherapy to a Moving Tumor Using Simplified Volumetric Modulated Arc Therapy.

Authors:  Young Eun Ko; Byungchul Cho; Su Ssan Kim; Si Yeol Song; Eun Kyung Choi; Seung Do Ahn; Byongyong Yi
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.